CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 498 enrolled
Drug / intervention
Start with SMSH+TIPC +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03494166
NCT03494166N/ACompleted

Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design

University of Arizona·interventional·Posted Apr 11, 2018·Updated Oct 19, 2023

In Brief

A clinical study evaluating Start with SMSH+TIPC and Start with SMSH alone for Cancer. Completed, enrolled 498 participants across 2 sites.

Detailed Summary

Survivors of solid tumors (N=451) who completed curative intent chemotherapy for a solid tumor within the past 2 years were interviewed at baseline and stratified as high or low need for symptom management based on comorbidity and depressive symptoms. High need survivors were randomized initially to the 12-week Symptom Management and Survivorship Handbook (SMSH, N=282) or 12-week SMSH Telephone Interpersonal Counseling (TIPC, N=93) added during weeks 1-8. After 4 weeks of the SMSH alone, non-responders on depression were re-randomized to continue with SMSH alone (N=30) or add TIPC (N=31).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 11, 2018
Enrollment StartJul 1, 2018
Primary CompletionJun 3, 2022
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 8.2 years ago

Interventions

Start with SMSH+TIPCbehavioral

See arm/group descriptions

Start with SMSH alonebehavioral

See arm/group descriptions